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1. Introduction 
Coronary angiography is an invasive technique for imaging the coronary artery lumen and 
remains one of the most accurate methods for diagnosing coronary artery disease. 
Furthermore, this invasive technique is the standard method for guiding revascularization 
procedures such as percutaneous coronary intervention (PCI) and coronary-artery bypass 
graft (CABG), as well as for guiding stent placement during PCI. However, the degree of 
coronary stenosis is usually decided by visual estimation of the percentage diameter 
narrowing using the proximal assumed normal arterial as a reference. There is 20% variation 
among readings of experienced angiographers, and the same angiographer may even render 
a different interpretation at a time remote from the first reading. Borderline stenosis, or 
angiographic narrowing of 40 to 70%, does not always correspond to abnormal physiology 
and myocardial ischemia (1,2). For such lesions, noninvasive or direct physiological 
measurements of impaired flow validate the decision to initiate revascularization therapy. 
Though quantitative coronary angiography can be reproduced for assessment of coronary 
stenosis, the inability to determine the functional severity of coronary stenosis remains a 
limitation of coronary angiography. 
Intracoronary physiological parameters have been introduced to assess functional coronary 
lesion severity during cardiac catheterization. Measurement of coronary flow reserve (CFR; 
coronary flow velocity response to adenosine) and fractional flow reserve (FFRmyo; 
coronary pressure-derived with adenosine) provide information about functional severity 
(3). Furthermore, FFRmyo, which is calculated from coronary pressure measurements, is an 
invasive index used to identify a stenosis responsible for reversible ischemia (4,5,6). 
For most patients with stable angina, the goal of treatment is complete, or nearly complete 
elimination of anginal chest pain and return to normal activities with a functional capacity 
corresponding to Canadian Cardiovascular Society (CCS) class I angina. This goal should be 
accomplished with minimal side effects, as well as with a reduced risk of mortality (7). The 
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topics of this chapter encompass the activities of daily life and functional stenosis in patients 
with angiographically demonstrated stenosis.  
2. Functional severity 
For coronary angiographic assessment employing cardiac catheterization, it should be noted 
that the stenotic lumen is compared to a nearby angiographically normal lumen, which may 
still show diffuse atherosclerotic disease. Furthermore, lesions containing diffuse, 
concentric, symmetrical disease, remodeling, or dissection, will be underestimated when 
disease severity is assessed (Fig.1). CFR and FFRmyo, which provide information about 
functional severity, can be performed during cardiac catheterization. 
 
 
(A) Stenosis can be visualized from multiple angles. (B) Stenosis can be viewed as indicated by the 
white arrow, but is normally visualized as indicated by the black arrow. Stricture necessitates changing 
the angle. (C)  Vascular conduits appear normal at all angles despite the existence of stenosis. 
Fig. 1. Angiographic images and vascular conduits  
CFR reflects both epicaudal and microvascular disease but does not identify these entities by 
itself (8,9). Intra-coronary flow velocity can be measured with a 0.014-inch doppler guide 
wire during baseline measurements and maximum hyperemia which is induced by 
administering adenosine. CFR was calculated as the ratio of hyperemic to baseline of the 
average peak velocity (10,11). CFR can also be measured with a temperature sensor-tipped 
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guidewire, as the ratio of the inverse mean transit times obtained by thermodilution curves 
at baseline and during hyperemia (12,13,14). The parameters of CFR show agreement at a 
cut-off value of 2.0 (11,15).  
On the other hand, FFRmyo is an accurate functional index of epicaudal stenosis (4,5). Intra-
coronary pressure can be measured with a 0.014-inch pressure-monitoring guidewire, which 
was first calibrated, then set to be equal with the aortic pressure in the guiding catheter, and 
finally positioned distal to the coronary lesion. Mean aortic and distal pressures were 
obtained during baseline measurements, and FFRmyo was calculated as the ratio of the 
mean distal pressure to the mean aortic pressure during maximum hyperemia (3,4,5). 
Although a previous report emphasized the importance of combining pressure and flow 
velocity measurements to evaluate coronary lesion severity and microvascular involvement 
(11), FFRmyo is a reliable index of the functional severity of coronary stenosis, and an 
FFRmyo value of 0.75 distinguishes stenoses associated with inducible ischemia from those 
that are not. Indeed, in patients with stable chest pain, the most important prognostic factor 
is the occurrence of myocardial ischemia reflected by an FFRmyo of < 0.75 (5,6, Fig.2).  
 
 
 
In the case on the left, angiographic stenosis was 56% in the left circumflex branch (LCX) by quantitave 
coronary angiography (A). During adenosine infusion, the wire was pulled back to track coronary 
pressure from the far distal LCX to the catheter, and after crossing the lesion produced a change in 
coronary pressure (FFRmyo = 0.58). 
Likewise, in the case shown on the right, angiographic stenosis was 46% in left anterior descending 
branch (LAD) by quantitative coronary angiography (C), and FFRmyo = 0.70 (D) 
Fig. 2. Representative case of FFRmyo 
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Even when treated with PCI, the clinical outcomes of these patients are significantly worse 
than those of patients with functionally insignificant stenoses (FFRmyo  0.75) (16,17). When 
FFRmyo was used to divide patients into a group in which stenosis was most likely to be 
physiologically significant (FFRmyo < 0.75) and a group in which it was not, the overlap 
between the 2 groups in terms of angiographic severity was so large that it suggested 
angiography (16,17) could not be used to predict the absence or presence of inducible 
ischemia in individual patients (4,18, Fig.3). In fact, however, in patients with multivessel 
coronary artery disease undergoing PCI with drug eluting stents, routine measurement of 
FFR in addition to angiographic guidance, as compared with PCI guided by angiography 
alone, results in a significant reduction in major adverse events (19). 
 
 
(A) The percent stenosis is likely to be physiological; FFRmyo. (B) The overlap between stenosis and 
FFRmyo was large. 
Fig. 3. Variations in percent stenosis on coronary angiography and FFRmyo  
3. Functional capacity 
The factors contributing to impaired exercise capacity appear to be multifactorial and 
include increasing age, sedentary lifestyle, depression, obesity and other comorbidities as 
well as impaired cardiovascular function. Poor exercise capacity is generally considered to 
be a predictor of mortality in patients with ischemic heart disease as well as all cause 
mortality (20,21). Traditional exercise tests such as the treadmill test or walking distance in 6 
minutes are well-known methods for measurement of exercise capacity. 
Additionally, self-assessed questionnaires, such as the Duke Activity Status INDEX (DASI) 
(22), the Specific Activity Questionnaire (SAQ) (23) and the Veterans Specific Activity 
Questionnaire (VSAQ) (24), can also measure exercise capacity as a well validated measure 
of functional capacity that can be expressed as metabolic equivalents (METs) and have been 
shown to correlate with adverse outcomes. Self-assessed questionnaires can be a simple and 
easy tool that contributes to the global risk assessment (10). 
The cardiopulmonary exercise test (CPX) is useful for measurement of excise capacity 
employing various parameters at each stage in a series of exercises (Fig.4). A symptom-limited 
incremental exercise test is usually performed using an upright, electromagnetically braked 
cycle ergometer or treadmill with measurement of breath-by-breath VO2, carbon dioxide 
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production (VCO2) and minute ventilation (VE). This evaluates peak VO2, oxygen uptake at 
the anaerobic threshold (AT) and so on. A 12-lead electrocardiogram (ECG) and heart rate 
were continuously monitored throughout the test, and cuff blood pressure was measured 
every minute using an automatic manometer. CPX testing is more useful than self-assessed 
health status, which is subjective and can vary among patients depending upon symptom 
complexity and the unique perceptions, expectations and preferences of individuals (7). 
 
 
Fig. 4. Representative case of CPX 
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4. Functional severity and exercise capacity in patients with angiographic 
stenosis 
Coronary angiography employing cardiac catheterization has an important role in 
revascularization procedures such as PCI, and PCI has become a common initial 
management strategy for patients with stable angiographic stenosis. However, at present, 
the initial management strategy of patients with stenosis on coronary angiography should 
be to reduce not only the risks for major cardiac events but also to eliminate angina and 
allow a return to normal activities. Previous studies have shown that PCI does not reduce 
the long-term rates of death, myocardial infarction or other major cardiovascular events 
with compared to optimal medical therapy alone (25). PCI can provide an incremental 
benefit in quality of life compared with that provided by optimal medical therapy alone 
among patients with chronic coronary artery disease for approximately 24 months (26). 
Another previous study showed that in patients with stable coronary artery disease and an 
angiographically documented stenosis treatable by PCI, a 12-month exercise-training 
program resulted in a higher event-free survival rate and higher exercise capacity than 
standard PCI (27). Additionally, PCI significantly increased exercise capacity values such as 
AT and peak VO2 in patients with peak VO2 < 15 ml/kg/min, whereas it yielded no 
significant improvement in those with peak VO2 ≥ 15 ml/kg/min (28). Based on these 
observations, the existence of stenosis on coronary angiography is an insufficient indication 
for revascularization. It has been reported that an increase in functional capacity as indicated 
by self-assessed questionnaire is associated with an increase in CFR, although 86% of subjects 
did not have significant stenosis on coronary angiography (10). Impaired overall functional 
capacity is independently associated with coronary microvascular dysfunction or endothelial 
dysfunction, among the most important determinants of myocardial ischemia. On the other 
hand, routine FFRmyo measurement with angiographic guidance resulted in a significant 
reduction in major adverse cardiac effects, even when patients underwent PCI with drug-
eluting stents (19). Furthermore, FFRmyo is associated with inducible ischemia which other 
measures are not, thereby providing higher accuracy than for any other invasive or 
noninvasive test. According to the aforementioned reports, it seemed that the existence of 
stenosis on coronary angiography is a notwell validated measure of stable angina. FFRmyo 
and functional capacity should be determined in stable angina patients with angiographic 
stenosis. Previously, we assessed the relationship between FFRmyo and CPX values (4). 
Our study subjects were 15 males (65.8+/-8.9 years old) with stable angina and 75% 
angiographic stenosis in one coronary artery. Eligible patients had no evidence of acute 
coronary syndromes, prior myocardial infarction, significant valvular heart disease, diabetes 
mellitus treated with insulin, smoking; or occupational, orthopedic and other conditions 
that precluded exercise. Neither did they have left main coronary artery stenosis > 25% or 
high-grade proximal left anterior descending artery stenosis with significant stenosis (> 
75%) of other vessels, nor left ventricular angiography-based detection of abnormal wall 
motions such as asynergy or diffuse hypokinesis, or reduced left ventricular function 
(ejection fraction < 55%). The %diameter stenosis (%DS) was determined to be 61.7+/-9.1% 
based on quantitative coronary angiography. Mean FFRmyo was 0.84+/-0.66, peak VO2 was 
17.1+/-3.2ml/kg/min and AT was 11.1+/-2.0ml/kg/min. There was no significant 
correlation between %DS and FFRmyo (r = 0.12, p = ns, Fig.3A), peak VO2 (r = -0.051, p = 
ns) or AT (r = -0.013, p = ns). By contrast, there was a significant positive correlation (Fig.5) 
between FFRmyo and peak VO2 (r = 0.534, p < 0.05) and between FFRmyo and AT (r = 
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0.542, p < 0.05). A previous study showed stable angina patients with impaired functional 
capacity as assessed by a CPX test to likely have reduced FFRmyo. The present study also 
showed that an FFRmyo value of 0.75 reflects stenoses associated with inducible ischemia 
and hence appears to correspond to a peak VO2 value of 15.0. A cut-off value of FFRmyo of 
0.75 nearly matched the exercise capacity value (peak VO2; 15 ml/kg/min) improvement 
with PCI. As noted above, exercise capacity in patients with stable angina reflects functional 
rather than angiographic stenosis. Exercise training can improve myocardial perfusion, as 
revealed by myocardial scintigraphy, as well as maximal exercise capacity (27). Therefore, 
that study suggested that it may be possible to improve FFRmyo by increasing exercise 
capacity through training. 
 
 
(A) There is no correlation between angiographic stenosis and peak VO2. However, there is a positive 
correlation between FFRmyo and peak VO2 (B). (Source: Circ J 2009;73: 2308–2314) 
Fig. 5. Relationship between exercise capacity and stenosis.  
4.1 Case report 
This is a representative case showing improvement in functional capacity despite the 
existence of angiographic stenosis. 
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A 58-year-old woman presented with unstable angina. Coronary angiography revealed 99% 
stenosis of the right coronary artery (RCA#3), and 75% stenosis (#11) and 90% stenosis (#12) 
of the left circumflex branch (LCX). She received stent implantation to #3 in the emergent 
stage (Fig.6). Thallium-201 scintigraphy with adenosine revealed ischemia in the LCX area 
(Fig.7A). PCI was recommended, but the patient refused because the condition was 
asymptomatic in her daily life. This patient did not wish to undergo revascularization of the 
LCX and continue to receive cardiac rehabilitation (physical training at AT level). Peak VO2 
increased from13.3 ml/kg/min (Fig.4) to 16.8 ml/kg/min. Thallium-201 scintigraphy 
(Fig.7B) with adenosine documented improved myocardial perfusion distal to the LCX. 
(Ischemia area reduced from 13.7% to 8.75%)  
 
 
There was (A) 99% stenosis of the right coronary artery (RCA #3) and a (B) stent was implanted. Left coronary 
angiongraphy revealed 75% stenosis (#11) and 90% stenosis (#12) of the left circumflex branch (LCX). 
Fig. 6. Coronary angiographies of case repor  
 
 
Fig. 7. Bull’s eye image from thallium-201 single-photon emission computed tomography 
(A) pre-training (ischemic area 13.7%), and (B) post-training (ischemic area 8.75%) 
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5. Functional severity, exercise capacity and tissue characterization 
Acute coronary syndrome is triggered by microscopic ulcerations of vulnerable 
atherosclerotic plaques. The majority of vulnerable plaques appear “angiographically 
insignificant” before their rupture (less than 75% diameter stenosis). In contrast, most of the 
“significant” plaques (greater than 75% stenosis) visualized at angiography are at low risk 
for plaque rupture (29).  
Intravascular ultrasound (IVUS) allows cross-sectional imaging of coronary arteries and 
provides a more comprehensive assessment of the atherosclerotic plaques in vivo (30, Fig 8). 
Studies using IVUS have indicated that coronary atherosclerosis is underestimated when 
visually analyzing angiographic results owing to coronary compensatory remodeling and 
the diffuse nature of coronary atherosclerosis, which frequently makes the reference vessel 
appear normal angiographically (31).  
 
 
Intravascular ultrasound provides an image of an atheroma in a normal segment (B,E) as well as a 
stenotic lesion (C,D) on angiography 
Fig. 8. Representative angiographic and IVUS images   
An integrated backscatter intravascular ultrasound (IB-IVUS) system has been developed in 
which two-dimensional color-coded maps allowing plaque tissue characterization in 
coronary arteries can be constructed by computer (32,33). A computer equipped with IB-
IVUS software is connected to the IVUS imaging system to obtain radio frequency signal 
output, signal trigger output, and video image output. IB is calculated as the average power 
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of the ultrasound backscattered signal from a small volume of tissue using fast Fourier 
transform measured in decibels (dB) (32). IB-IVUS is a useful method for analyzing coronary 
plaque tissue (Fig.9), which accurately and quantitatively differentiates among calcification, 
dense fibrosis, fibrosis and lipid components (33). IB-IVUS results previously suggested that 
classifying plaques as vulnerable or stable using this technique is an effective means of 
predicting acute coronary syndrome. When evaluated using IB-IVUS, plaques are deemed 
vulnerable when the lipid area is > 65% and the fibrotic area is < 25% (30). Thus, functional 
stenosis and tissue characterization may be linked to clinical outcome. Previously, we 
assessed the relationship between functional stenosis and the characterization of plaque 
tissue using FFRmyo and IB-IVUS (18).  
 
 
The initial image was constructed by tracing the lumen and the external elastic membrane. In the color-
coded map, red is calcification, yellow and green are fibrosis, and blue represents the lipid pool. 
Fig. 9. Representative IB-IVUS images  
We studied 17 lesions showing 75%-stenosis visually by coronary angiography in 17 stable 
angina patients (64.2+/-9.1 years old, 11 males). We found no correlation between FFRmyo 
and %DS (r = -0.354, p = 0.166, Fig.3B). Nor was there a correlation between FFRmyo and 
plaque burden (r = -0.241, p = 0.359, Fig.1B), or between FFRmyo and minimum lumen 
cross-sectional area (r = -0.002, p = 0.995). Likewise, neither %DS nor plaque burden 
correlated with the tissue characterization values (Figs.10A). There was no correlation 
between FFRmyo and %CA (calcification area) (r = -0.068, p = 0.799). By contrast, we 
observed a significant positive correlation between FFRmyo and %F (r = 0.620 p = 0.0067), 
and a significant negative correlation between FFRmyo and %LP (lipid pool area) (r = -0.524, 
p = 0.0293) (Fig.10B).  
Our previous findings indicate that the tissue characteristics of coronary plaques in 
intermediate lesions affect functional stenosis. Fibrous tissue and FFRmyo also correlate 
positively. Lipid pool and FFRmyo correlate negatively. The apparently contradictory 
results obtained in this study might be explained by the progression of human 
atherosclerotic lesions leading to increasing fibrosis and stenosis. Distal pressure, 
additionally, decreases with the severity of coronary narrowing in the epicardial arteries, 
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contributing to the progression of atherosclerosis. However, intermediate or moderate 
lesions remain distinct in terms of functional and angiographic severity. The increase in 
fibrous tissue is likely an adaptive response to this distal pressure aimed at redistributing 
and modulating the mechanical stress (34). The increased fibrosis may also be an adaptive 
response to reduced elasticity of the arterial wall in the area of the lesion. An earlier in vivo 
study showed that elasticity in the area of stenosis can exacerbate the pressure drop across 
the lesion, thereby reducing flow (35). 
 
 
(A) There was no correlation between angiographic stenosis and tissue characterization (B). There was a 
significant positive correlation between FFRmyo and fibrosis, and a significant negative correlation 
between FFRmyo and the lipid pool: ▲, %CA = percent calcification area; □, %F = percent fibrotic area; 
●, %LP = percent lipid pool area. (Source: J. Cardiol; 2010 ;55,296—302) 
Fig. 10. Relationship between stenosis and tissue characterization  
Our studies showed that angina patients with reduced FFRmyo are likely to have reduced 
functional capacity, and that the tissue characteristics of coronary plaques in intermediate 
lesions affect functional stenosis. According to these studies, high exercise capacity in 
patients with stable angiographic stenosis is linked to the stability of coronary plaques. 
Another report on coronary computed tomographic angiography indicated that coronary 
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plaque characteristics were identified in patients with progressively reduced exercise times, 
and that functional ischemia was more severe in those with mixed plaque. (36) 
Thus, though coronary angiography is one of the most accurate methods for diagnosing 
coronary artery disease, comprehensive assessment of health status is necessary for stable 
angina patients with angiographic stenosis.  
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Coronary artery disease (CAD) and its consequences are most important morbidity and mortality reasons in
the developed and developing countries. To prevent hard end-points, early definitive diagnosis and optimum
therapy play significant role. Novel advanced diagnostic tests which are biomarkers of inflammation, cell
adhesion, cell activation and imaging techniques provide to get the best result in the detection and
characterization of calcified or uncalcified atherosclerotic plaques. In spite of last developments in the imaging
methods, coronary catheterization is still frequently performed. Following the first cardiac catheterization
performed in 1844, date by date historical developments and the mechanics of cardiac catheterization
techniques, risks associated with coronary angiography, and also, preventions and treatments of possible
complications have been presented in this book. Other important issue is radiation exposure of patients and
staff during coronary angiography and scintigraphy. Radiation dose reduction techniques, general radiation
protection principles have been discussed in related chapters.
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